|

CD64 CAR T Cells Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • University of Colorado, Denver1

Indications

  • Relapsed Acute Myeloid Leukemia (AML)1
  • Refractory Acute Myeloid Leukemia (AML)1
  • AML - Acute Myeloid Leukemia1
  • Myelodysplastic Syndrome1
  • Cancer1

Aurora, Colorado1 trial

CD64 CAR T Cell Therapy in Adults With Relapsed and/or Refractory AML

University of Colorado Hospital

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.